Clinical trials for

Drug Eluting Stent

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingInterventional

Istanbul, Turkey (Türkiye)Check eligibility →

RecruitingInterventional

Suwon, Gyeonggi-do, South KoreaCheck eligibility →

RecruitingInterventional

Alicante, Spain +4 moreCheck eligibility →

RecruitingPost-approval study

Bucheon-si, South Korea +4 moreCheck eligibility →

RecruitingInterventional

Chrzanów, Chrzanow, PolandCheck eligibility →

RecruitingInterventional

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingInterventional

Xi'an, Shannxi, ChinaCheck eligibility →

RecruitingInterventional

Banja Luka, Bosnia and Herzegovina +4 moreCheck eligibility →

RecruitingInterventional

Anyang, South Korea +4 moreCheck eligibility →

RecruitingLarge-scale testing

Karachi, PakistanCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingInterventional

Aalst, Belgium +4 moreCheck eligibility →

RecruitingInterventional

Beijing, Beijing Municipality, China +4 moreCheck eligibility →

RecruitingObservational

Aix-en-Provence, France +4 moreCheck eligibility →

RecruitingObservational

Xi'an, Shannxi, ChinaCheck eligibility →

RecruitingPost-approval study

Aalborg, Denmark +2 moreCheck eligibility →

RecruitingInterventional

Xi'an, Shaanxi, ChinaCheck eligibility →

RecruitingObservational

Suwon, South KoreaCheck eligibility →

RecruitingInterventional

Atlanta, Georgia, United States +4 moreCheck eligibility →

RecruitingInterventional

Ansan, South Korea +4 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingInterventional

Istanbul, Turkey (Türkiye)Check eligibility →

RecruitingInterventional

Suwon, Gyeonggi-do, South KoreaCheck eligibility →

RecruitingInterventional

Alicante, Spain +4 moreCheck eligibility →

RecruitingPost-approval study

Bucheon-si, South Korea +4 moreCheck eligibility →

RecruitingInterventional

Chrzanów, Chrzanow, PolandCheck eligibility →

RecruitingInterventional

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingInterventional

Xi'an, Shannxi, ChinaCheck eligibility →

RecruitingInterventional

Banja Luka, Bosnia and Herzegovina +4 moreCheck eligibility →

RecruitingInterventional

Anyang, South Korea +4 moreCheck eligibility →

RecruitingLarge-scale testing

Karachi, PakistanCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingInterventional

Aalst, Belgium +4 moreCheck eligibility →

RecruitingInterventional

Beijing, Beijing Municipality, China +4 moreCheck eligibility →

RecruitingObservational

Aix-en-Provence, France +4 moreCheck eligibility →

RecruitingObservational

Xi'an, Shannxi, ChinaCheck eligibility →

RecruitingPost-approval study

Aalborg, Denmark +2 moreCheck eligibility →

RecruitingInterventional

Xi'an, Shaanxi, ChinaCheck eligibility →

RecruitingObservational

Suwon, South KoreaCheck eligibility →

RecruitingInterventional

Atlanta, Georgia, United States +4 moreCheck eligibility →

RecruitingInterventional

Ansan, South Korea +4 moreCheck eligibility →

62 trials · Recruiting

62

Trials actively recruiting patients for Drug Eluting Stent

Trial status

Phase

Location